CD38 and B-cell chronic lymphocytic leukemia: The percentage of intermediate monocytes in groups ZAP-70+ and CD38+ were significantly higher than ZAP-70− and CD38− in MLR-high CLL patients (median, IQR; 10.99, 12.18–9.11, vs. 7.51, 8.98–7.0, p=0.0082 and median, IQR; 10.23, 12.0–9,01 vs. 7.51, 8.26–5.64, p=0.0062) (Figures 6(b), 6(e)).